[Efficacy and safety of long-term complementary treatment with standardized European mistletoe extract (Viscum album L.) in addition to the conventional adjuvant oncologic therapy in patients with primary non-metastasized mammary carcinoma. Results of a multi-center, comparative, epidemiological cohort study in Germany and Switzerland].
Arzneimittelforschung. 2004;54(8):456-66. doi: 10.1055/s-0031-1296999. Arzneimittelforschung. 2004. PMID: 15460213 Clinical Trial. German.